In vitro skin sensitizing quantitative potency assessment
GARDskin Dose-Response is an in vitro test for quantitative skin sensitizing potency assessment of chemicals, adapted from GARDskin.
GARDskin Dose-Response provides an estimated threshold concentration for a test substance to induce skin sensitizing effects; a lower concentration equals a higher potency and vice versa. This threshold concentration can be used for skin sensitizing potency ranking of candidate ingredients and early decision-making during product development.
Additionally, the readout can be extrapolated to a correlating LLNA EC3 value, which is traditionally used to measure the skin sensitizing potency of chemicals. Furthermore, the readout can also be extrapolated to human skin sensitizing potency and/or GHS/CLP classification (1A or 1B), all with high statistical significance.
DOWNLOAD PRODUCT FACTS
Are you looking for dose-response data?
GARDskin Dose-Response gives both qualitative and quantitative information related to skin sensitization. The non-animal test data can be used to predict:
- LLNA EC3 value
- Human skin sensitizing potency
- GHS/CLP classification (1A or 1B)
Gradin et al., Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin. Nature Scientific Reports. September 23, 2021.
The number of biomarkers used in GARDskin Dose-Response.